Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Turoctocog Alfa in Paediatric PUPs with Haemophilia A
NCT01493778Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2012
- Primary completion
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 18
01
Overview
A Phase 3 trial of turoctocog alfa in hemophilia A, sponsored by Novo Nordisk. Started Sep 2012; status: completed.
02
Drugs
turoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01493778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493778.